[Decision making factors of the management of ductal carcinoma in situ of the breast with microinvasion]. / Facteurs décisionnels de la prise en charge des carcinomes canalaires in situ du sein avec micro-invasion.
Bull Cancer
; 106(11): 1000-1007, 2019 Nov.
Article
em Fr
| MEDLINE
| ID: mdl-31351573
ABSTRACT
INTRODUCTION:
Microinvasive in situ ductal carcinomas of the breast are rare and of good prognosis. They are grouped with early stage invasive carcinomas in the TNM 2017 classification. This study assessed practitioners' treatment decisions and their justifications in comparison to the literature. MATERIALS ANDMETHODS:
Three clinical cases were evaluated by anonymous forms regarding sentinel node decisions, tumour bed boost irradiation and hormone therapy.RESULTS:
Sentinel lymph node was performed by 93.1%, 100% and 44.4% of the practitioners respectively. Radiation boost was a treatment option chosen by 62.1% and 61.1% of practitioners in both clinical cases. Hormone therapy was advocated for 65.5%, 94.7% and 50.0% patients depending on the clinical case.CONCLUSION:
The therapeutic attitude proposed in microinvasive breast carcinomas was heterogeneous in this study, reflecting the absence of specific recommendations. In view of the existing literature, it is not currently possible to propose recommendations for these three therapeutic options. Prospective cohorts and meta-analyses of the microinvasive subgroup could provide answers.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Mama
/
Carcinoma Intraductal não Infiltrante
/
Biópsia de Linfonodo Sentinela
/
Tomada de Decisão Clínica
Tipo de estudo:
Guideline
/
Prognostic_studies
Limite:
Adult
/
Female
/
Humans
/
Middle aged
Idioma:
Fr
Revista:
Bull Cancer
Ano de publicação:
2019
Tipo de documento:
Article
País de afiliação:
França